Hybrid Type 1 Effectiveness Implementation Trial of a Proactive Smoking Cessation Electronic Visit for Scalable Delivery via Primary Care

Sponsor:

NIH

Sponsor Study ID:

R01 CA258669

CTO #:

103509

NCT Number:

NCT05493254

Phase:

II

Protocol Type:

Prevention

Age Group:

Adults

Disease Sites:

Study Objectives:

We will conduct a two-arm clinic-randomized clinical trial (N=672) to examine the effectiveness of a smoking cessation electronic visit (e-visit) vs. treatment as usual (TAU) for smoking cessation across 21 MUSC primary care practices. Main outcomes include: 1) evidence-based smoking cessation treatment utilization (medication, psychosocial cessation counseling), 2) reduction in cigarettes per day, and 3) biochemically verified 7-day PPA at six-month follow-up. We hypothesize that smokers randomized to the e-visit condition will have significantly better cessation outcomes relative to TAU. Secondary outcomes will focus on implementation of the e-visit at the patient, provider, and organizational levels.

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)